Skip to main content

Table 5 Summary of ADCmean and ADCmin values per histopathological group

From: Role of diffusion weighted MR-imaging in the evaluation of malignant mediastinal lesions

Pathological entity Number of cases and percentage (%) ADCmean range average ± SD* ADCmin range average ± SD*
Lymphoma 9 (27.3%) (0.507–1.08)
0.733 ± 0.191
(0.343–0.846)
0.541 ± 0.164
Central bronchogenic carcinoma 10 (30.3%) (0.501–1.633)
0.904 ± 0.342
(0.354–1.474)
0.747 ± 0.336
Metastatic lymph nodes 4 (12.1%) (0.667–1.391)
1.033 ± 0.3
(0.467–1.212)
0.822 ± 0.307
Thymic tumors 4 (12.1%) (0.847–1.233)
0.959 ± 0.184
(0.708–1.111)
0.827 ± 0.191
Germ cell tumors 4 (12.1%) (0.568–2.44)
1.058 ± 0.921
(0.431–1.701)
0.776 ± 0.616
Neurogenic tumors 1 (3.03%) 0.473 0.327
Angiosarcoma 1 (3.03%) Could not be measured**
Total 33 (100%) 0.884 ± 0.396 0.699 ± 0.326
  1. All values are expressed in units of 10−3 × mm2/s
  2. *SD Standard deviation
  3. **Elaborated later